SEC EDGAR CompanyFacts fact · reporting period
Arcus Biosciences, Inc.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$258.000M{"amount": 258000000, "concept": "us-gaap:Revenues", "currency": "USD"}- Entity
- Arcus Biosciences, Inc.
- Metric
- revenue
- Period
- 2024-01-01 – 2024-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T14:27:31.819470+02:00
Raw response SHA-256
981bcf685d97980729b8322b805b8290…Official-identifier path
https://factanker.com/fact/sec/cik-0001724521/revenue/2024-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 51000000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001724521-25-000040)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.